Michael Köttgen (ORCID 0000-0003-2406-5039) has 85 indexed works with ~5,237 citations and an h-index of 33 (OpenAlex; Scopus-consistent metrics: h-index 31, ~4,475 citations, 71 papers). Citation flow is sustained and recent — roughly 300–385 citations per year from 2020–2026 — indicating continued relevance rather than reliance on legacy citations alone. Topic profiles concentrate in biology, cell biology, kidney, and genetics.
His flagship contribution, the 2009 PNAS paper, demonstrates gene function behind a GWAS signal: ABCG2 mediates urate efflux (75.5% reduction in urate accumulation in ABCG2-expressing oocytes vs. controls), localizes apically in polarized LLC-PK1 cells, and the common Q141K variant reduces transport by 54% . Population genetics in ARIC (10,902 white and 3,881 black participants for urate) gave P trend = 3×10⁻³⁰ (whites) and 7×10⁻⁴ (blacks), with an OR of 1.68 per T allele for gout and an estimated 10% population-attributable risk in whites . This functional-plus-population design is a template for causal GWAS follow-up. Limitations to note: gout was self-reported, the black cohort had only 3% minor allele frequency (requiring genotype pooling), and functional work relied on heterologous oocyte and porcine cell models rather than human proximal tubule.
The publication list spans ion-channel biology (TRPP2, TRPV4), polycystic kidney disease mechanisms (DNAJB11 co-chaperones, 3D tubulogenesis assays, deep-learning image quantification), metabolite GWAS in Nature Genetics, and — most recently — computational cell-type assignment (CellMatchR with TabPFN machine learning, 2026) . The 2026 paper shows healthy self-critical practice: cross-dataset accuracy is honestly reported as modest (~56–59%), negative controls were used (10% false positives with Spearman, 0% with ML), and a conflict of interest (TabPFN co-founder) is disclosed. Earlier URAT1 GWAS work in African Americans extended the urate-transporter genetics program across ancestries .
Overall: a rigorous, mechanistically oriented, methodologically adaptive kidney scientist whose strongest work bridges gene function and population genetics with quantified, reproducible evidence. Confidence: high for career metrics and ABCG2 findings; moderate for newer computational work given limited independent replication.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.